MiDAS III (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study
MiDAS III
1 other identifier
interventional
138
1 country
27
Brief Summary
This is a multi-center, prospective, observational clinical study to compare patient outcomes following treatment with either the mild® procedure or epidural steroid injection in patients with moderate to severe lumbar spinal stenosis exhibiting neurogenic claudication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2011
Typical duration for not_applicable
27 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 11, 2011
CompletedFirst Posted
Study publicly available on registry
March 15, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedResults Posted
Study results publicly available
August 19, 2015
CompletedAugust 31, 2015
August 1, 2015
3.2 years
March 11, 2011
June 1, 2015
August 19, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Participants With a 2-point Improvement in Visual Analogue Scale
The primary endpoint for evaluating effectiveness will be the proportion of subjects in each group achieving at least a 2-point improvement from baseline in the Visual Analog Scale.
16 weeks
Study Arms (2)
Percutaneous Lumbar Decompression
ACTIVE COMPARATORPatients receiving percutaneous decompression using the mild® Device Kit.
Lumbar Epidural Steroid Injection
ACTIVE COMPARATORInjection of epidural steroids into the lumbar spine
Interventions
The percutaneous procedure is performed under fluoroscopic guidance to effect a lumbar decompression with minimal surrounding tissue and bone disruption. The mild® Device Kit is utilized to access, capture and remove bone and tissue.
Injection of epidural steroids into the lumbar spine
Eligibility Criteria
You may qualify if:
- Lumbar spinal stenosis (LSS) with neurogenic claudication where the Visual Analog Scale (VAS) of back and leg pain average is ≥ 5.
- Prior failure of conservative therapy.
- Oswestry Disability Index (ODI) score of ≥ 31%.
- Radiologic evidence of LSS, with unilateral or bilateral ligamentum flavum ≥ 4.1mm confirmed by pre-op MRI performed within 6-12 months of baseline visit.
- Able to walk ≥ 10 feet before being limited by pain.
- Available to complete 24-months of follow-up.
- Adults ≥ 50 years of age.
You may not qualify if:
- Prior surgery at intended treatment level.
- History of spinal fractures with current related pain symptoms.
- Motor deficit or disabling back and/or leg pain from causes other than LSS neurogenic claudication (e.g. acute compression fracture, metabolic neuropathy, vascular claudication symptoms, etc.).
- Significant/symptomatic disc protrusion or osteophyte formation judged by the Investigator as possible confounding factor to study results.
- Excessive facet hypertrophy judged by the Investigator as possible confounding factor to study results.
- Significant symptomatic foraminal stenosis.
- Confirmed anterior or retro-listhesis ≥ 3mm.
- Bleeding disorders and/or current use of anti-coagulants with the inability to withhold anticoagulants for required time prior to procedure.
- Able to walk ≥ 200 yards unaided in erect non-flexed position before being limited by pain.
- Able to stand ≥ 15 minutes in erect, non-flexed position before being limited by pain.
- Use of acetylsalicylic acid (ASA) and/or non-steroidal anti-inflammatory drug (NSAID) within 7 days of treatment.
- Pregnant and/or breastfeeding.
- Body mass index (BMI) ≥ 32 as calculated using the patient's weight multiplied by 703 then divided by height in inches squared.
- Epidural steroid, systemic steroid or any spine interventional procedure within prior six weeks of study procedure.
- Dementia and/or inability to give informed consent and to understand and complete follow-up patient reported outcomes forms.
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (27)
HOPE Research Institute
Phoenix, Arizona, 85050, United States
Center for Pain and Supportive Care
Scottsdale, Arizona, 85257, United States
Pain Clinic of Monterey Bay
Aptos, California, 95003, United States
Pain Control Associates of San Diego
Chula Vista, California, 91914, United States
Navarro Pain Control Group, Inc.
Solana Beach, California, 92075, United States
IPM Medical Group, Inc.
Walnut Creek, California, 94598, United States
The GW Pain Center
Washington D.C., District of Columbia, 20037, United States
Interventional Pain Physicians of South Florida
Aventura, Florida, 33108, United States
Coastal Orthopedics and Sports Medicine
Bradenton, Florida, 34209, United States
Holy Cross Interventional Spine & Pain Medicine Center
Fort Lauderdale, Florida, 33334, United States
Space Coast Pain Institute
Merritt Island, Florida, 32953, United States
Millennium Pain Center
Bloomington, Illinois, 61701, United States
Commonwealth Pain Specialists, PLLC
Frankfort, Kentucky, 40601, United States
The Spine Center Baltimore
Baltimore, Maryland, 21211, United States
Michigan Pain Specialists
Ann Arbor, Michigan, 48105, United States
Michigan Interventional Pain Center
Brownstown Twp., Michigan, 48183, United States
Occupational and Pain Management Professionals
Crystal City, Missouri, 63019, United States
Lab2Marche' LLC
Las Vegas, Nevada, 89149, United States
Virtua Pain and Spine Specialists
Voorhees Township, New Jersey, 08043, United States
Stony Brook University Medical Center
Stony Brook, New York, 11794, United States
The Center for Clinical Research, LLC
Winston-Salem, North Carolina, 27103, United States
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Neurospine Institute
Eugene, Oregon, 97401, United States
Axis Spine Care
Tyler, Texas, 75701, United States
Space City Pain Specialists, LLP
Webster, Texas, 77598, United States
The Center for Pain Relief, Inc.
Charleston, West Virginia, 25301, United States
The Center for Pain relief Tri-State
Huntington, West Virginia, 25702, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- VP of Clinical Affairs
- Organization
- Vertos Medical
Study Officials
- PRINCIPAL INVESTIGATOR
Nagy Mekhail, MD
The Cleveland Clinic
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2011
First Posted
March 15, 2011
Study Start
March 1, 2011
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
August 31, 2015
Results First Posted
August 19, 2015
Record last verified: 2015-08